{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T11:09:05Z","timestamp":1778411345593,"version":"3.51.4"},"reference-count":9,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T00:00:00Z","timestamp":1778371200000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Erdheim-Chester Disease (ECD) is an extremely rare non-Langerhans cell histiocytosis involving MAPK pathway mutations, notably BRAFV600E. We report a 60-year-old male with a history of BRAF-negative malignant melanoma and a new melanoma in situ, who presented with diabetes insipidus, hypogonadism, ataxia, blurred vision, dysarthria, headache, personality changes, and disturbed sleep patterns with kicking and mumbling. Neurological and systemic features raised suspicion for malignancy. PET imaging was more informative than CT or MRI and identified widespread FDG-avid skeletal and soft tissue lesions. Because of skeletal lesions, a bone marrow biopsy was performed despite a normal complete blood count and proved valuable as compared to biopsy of less accessible tissues. Histopathology from skin and bone marrow confirmed ECD with BRAFV600E mutation. This case highlights the diagnostic role of PET and bone marrow biopsy in ECD diagnosis. Multidisciplinary evaluation and targeted therapy with a BRAF inhibitor led to symptom resolution.<\/jats:p>","DOI":"10.1093\/omcr\/omag049","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:46:55Z","timestamp":1773233215000},"source":"Crossref","is-referenced-by-count":0,"title":["From suspected brain malignancy to Erdheim-Chester disease: the role of PET imaging and bone marrow biopsy in diagnosis"],"prefix":"10.1093","volume":"2026","author":[{"given":"Abdulrahman","family":"Al-Abdulmalek","sequence":"first","affiliation":[{"name":"Division of hematology, McGill University Health Centre , 1001 boulevard Decarie, Montreal, QC, H4A3J1 ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6249-1659","authenticated-orcid":false,"given":"Stephane","family":"Isnard","sequence":"additional","affiliation":[{"name":"Research Institute of the McGill University Health Centre , 1001 boulevard Decarie, Montreal, QC, H4A3J1 ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew A","family":"Watters","sequence":"additional","affiliation":[{"name":"Department of Pathology, McGill University , 1001 boulevard Decarie, Montreal, QC, H4A 3J1 ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9897-7589","authenticated-orcid":false,"given":"Jean-Pierre","family":"Routy","sequence":"additional","affiliation":[{"name":"Division of hematology, McGill University Health Centre , 1001 boulevard Decarie, Montreal, QC, H4A3J1 ,","place":["Canada"]},{"name":"Research Institute of the McGill University Health Centre , 1001 boulevard Decarie, Montreal, QC, H4A3J1 ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,5,10]]},"reference":[{"key":"2026051007063548700_ref1","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1182\/blood.2019003507","article-title":"Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era","volume":"135","author":"Goyal","year":"2020","journal-title":"Blood."},{"key":"2026051007063548700_ref2","first-page":"3257","article-title":"Erdheim-Chester disease: a comprehensive review","volume":"34","author":"Abdelfattah","year":"2014","journal-title":"Anticancer Res"},{"key":"2026051007063548700_ref3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1182\/bloodadvances.2016001784","article-title":"The clinical spectrum of Erdheim-Chester disease: an observational cohort study","volume":"1","author":"Estrada-Veras","year":"2017","journal-title":"Blood Advances"},{"key":"2026051007063548700_ref4","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood."},{"key":"2026051007063548700_ref5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s40262-024-01352-9","article-title":"Clinical evaluation of the effect of Encorafenib on bupropion, Rosuvastatin, and Coproporphyrin I and considerations for statin Coadministration","volume":"63","author":"Piscitelli","year":"2024","journal-title":"Clin Pharmacokinet"},{"key":"2026051007063548700_ref6","doi-asserted-by":"publisher","first-page":"110281","DOI":"10.1016\/j.clinimag.2024.110281","article-title":"Central nervous system involvement in Erdheim-Chester disease: a magnetic resonance imaging study","volume":"115","author":"Zahergivar","year":"2024","journal-title":"Clin Imaging"},{"key":"2026051007063548700_ref7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/acn3.51014","article-title":"Neurological manifestations of Erdheim\u2013Chester disease","volume":"7","author":"Boyd","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"2026051007063548700_ref8","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.ejrad.2015.04.022","article-title":"The role of 18FDG, 18FDOPA PET\/CT and 99mTc bone scintigraphy imaging in Erdheim\u2013Chester disease","volume":"84","author":"Garc\u00eda-G\u00f3mez","year":"2015","journal-title":"Eur J Radiol"},{"key":"2026051007063548700_ref9","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s00277-018-3436-0","article-title":"Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th meeting of the European Association for Haematopathology (EAHP) organized by the European bone marrow working group, Basel 2016","volume":"97","author":"Tzankov","year":"2018","journal-title":"Ann Hematol"}],"container-title":["Oxford Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/omcr\/article-pdf\/2026\/5\/omag049\/68262411\/omag049.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/omcr\/article-pdf\/2026\/5\/omag049\/68262411\/omag049.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T11:06:43Z","timestamp":1778411203000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/omcr\/article\/doi\/10.1093\/omcr\/omag049\/8675269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,9]]}},"URL":"https:\/\/doi.org\/10.1093\/omcr\/omag049","relation":{},"ISSN":["2053-8855"],"issn-type":[{"value":"2053-8855","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,5]]},"article-number":"omag049"}}